TAILIEUCHUNG - Familial breast cancer - The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care

Healthcare professionals should discuss the purpose, duration, frequency and location of follow-up with each man with localised prostate cancer8 , and if he wishes, his partner or carers. Men with prostate cancer should be clearly advised about potential longer term adverse effects and when and how to report them. Men with prostate cancer who have chosen a watchful waiting regimen with no curative intent should normally be followed up in primary care in accordance with protocols agreed by the local urological cancer MDT and the relevant primary care organisation(s). Their PSA should be measured at least once a. | Issue date October 2006 NHS National Institute for Health and Clinical Excellence Familial breast cancer This is a partial update of NICE clinical guideline 14 NICE clinical guideline 41 Developed by the National Collaborating Centre for Primary Care The classification and care of women at risk of familial breast cancer in primary secondary and tertiary care NICE clinical guideline 41 Familial breast cancer the classification and care of women at risk of familial breast cancer in primary secondary and tertiary care Ordering information You can download the following documents from CG041 The NICE guideline this document - all the recommendations. A quick reference guide - a summary of the recommendations for healthcare professionals. Understanding NICE guidance - information for patients and carers. The full guideline - all the recommendations details of how they were developed and summaries of the evidence they were based on. For printed copies of the quick reference guide or Understanding NICE guidance phone the NHS Response Line on 0870 1555 455 and quote N1130 quick reference guide N1131 Understanding NICE guidance . This guidance is written in the following context This guidance represents the view of the Institute which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. The guidance does not however override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient in consultation with the patient and or guardian or carer. National Institute for Health and Clinical Excellence MidCity Place 71 High Holborn London WC1V 6NA National Institute for Health and Clinical Excellence October 2006. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial

• Y học thường thức
• Myxozoa
• Metazoan Parasaites
• European Sea Bass
• Analysis Using
• Strategic Cost
• Management Practices
• Measurement Problems
• proved tactless
• turbulent and disposed
• Forwarding
• Parasitic Diseases
• Transmission Biology
• intelligence and shrewdness
• environmental changes